Alimemazine

Revision as of 19:18, 10 April 2015 by Kiran Singh (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Alimemazine
Clinical data
Pregnancy
category
  • AU: C
Routes of
administration
Oral
ATC code
Pharmacokinetic data
MetabolismHepatic
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC18H22N2S
Molar mass298.447 g/mol

WikiDoc Resources for Alimemazine

Articles

Most recent articles on Alimemazine

Most cited articles on Alimemazine

Review articles on Alimemazine

Articles on Alimemazine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Alimemazine

Images of Alimemazine

Photos of Alimemazine

Podcasts & MP3s on Alimemazine

Videos on Alimemazine

Evidence Based Medicine

Cochrane Collaboration on Alimemazine

Bandolier on Alimemazine

TRIP on Alimemazine

Clinical Trials

Ongoing Trials on Alimemazine at Clinical Trials.gov

Trial results on Alimemazine

Clinical Trials on Alimemazine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Alimemazine

NICE Guidance on Alimemazine

NHS PRODIGY Guidance

FDA on Alimemazine

CDC on Alimemazine

Books

Books on Alimemazine

News

Alimemazine in the news

Be alerted to news on Alimemazine

News trends on Alimemazine

Commentary

Blogs on Alimemazine

Definitions

Definitions of Alimemazine

Patient Resources / Community

Patient resources on Alimemazine

Discussion groups on Alimemazine

Patient Handouts on Alimemazine

Directions to Hospitals Treating Alimemazine

Risk calculators and risk factors for Alimemazine

Healthcare Provider Resources

Symptoms of Alimemazine

Causes & Risk Factors for Alimemazine

Diagnostic studies for Alimemazine

Treatment of Alimemazine

Continuing Medical Education (CME)

CME Programs on Alimemazine

International

Alimemazine en Espanol

Alimemazine en Francais

Business

Alimemazine in the Marketplace

Patents on Alimemazine

Experimental / Informatics

List of terms related to Alimemazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Alimemazine (INN), also known as trimeprazine (former BAN and USAN; trade names Nedeltran, Panectyl, Repeltin, Therafene, Theralen, Theralene, Vallergan, Vanectyl, or Temaril), commonly provided as a tartrate salt, is a phenothiazine derivative that is used as an antipruritic (it prevents itching from causes such as eczema or poison ivy, by acting as an antihistamine).[1] It also acts as a sedative and anti-emetic for prevention of motion sickness. Although it is structurally related to drugs such as chlorpromazine (Thorazine), it is not used as an anti-psychotic treatment.[2] It is no longer available in the United States.[3]

References

  1. "PubChem CID 78032".
  2. "Drugbank:Trimeprazine".
  3. "MedlinePlus:Trimeprazine".

Template:WikiDoc Sources